About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Mankind Pharma Ltd.
BSE Code
543904
ISIN Demat
INE634S01028
Book Value
363.64
NSE Code
MANKIND
Dividend Yield %
0.00
Market Cap
1059200.20
P/E
58.39
EPS
43.95
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
15-Sep-2025
2562.65
2593.00
2562.60
2583.45
122587
315955434
12-Sep-2025
2591.05
2619.85
2565.05
2579.85
4227
10936041
11-Sep-2025
2607.00
2615.40
2582.00
2596.75
5564
14456717
10-Sep-2025
2589.10
2625.00
2565.70
2608.80
8695
22514304
09-Sep-2025
2579.35
2601.95
2554.00
2589.50
4886
12653587
08-Sep-2025
2550.60
2595.00
2518.95
2578.60
6242
15969616
05-Sep-2025
2566.05
2590.00
2546.30
2551.50
4057
10404783
04-Sep-2025
2600.15
2602.30
2562.50
2566.10
8378
21650412
03-Sep-2025
2543.50
2583.50
2534.75
2559.60
18596
47680553
02-Sep-2025
2522.05
2558.35
2522.05
2543.00
6399
16263810
01-Sep-2025
2468.55
2525.00
2468.55
2518.95
7931
19826408
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.